- POSITIVE
Quarterly Revenue Artemis Medicare Serv Sep-2026 Quarterly Revenue is Rs 314 Cr which is growth of 13.1% YoY.
- POSITIVE
Quarterly Net Profit Artemis Medicare Serv Sep-2026 Quarterly Net Profit is Rs 31 Cr which is growth of 3.3% YoY.
Artemis Medicare Serv Live Share Price Today, Share Analysis and Chart
NSE 30 Oct, 2026 3:31 PM (IST)
Artemis Medicare Serv Stock Price Analysis
Day Price Range-1.6% 1 Day return | 293.2 (LTP) 287.7302.2 LowHigh |
|---|---|
Week Price Range2.9% 1 Week return | 293.2 (LTP) 276304.1 LowHigh |
Month Price Range-20.0% 1 Month return | 293.2 (LTP) 276370.1 LowHigh |
52 Week Price Range16.1% 1 Year return | 293.2 (LTP) 203.4378.8 LowHigh |
Artemis Medicare Serv Forecaster - Analyst Share Price Target and Estimates
Revenue forecast
EPS forecast
Consensus Recommendation
Artemis Medicare Serv quarterly results: revenue, profit, and P&L – 13 quarter history
| Indicator | Graph | Sep '26 | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 313.9 | 287.4 | 281.5 | 274.6 | 277.6 | 256.8 | 247 | 235.7 | 242.2 | 221.3 | 218.7 | 212 | 219.4 | ||
Operating Exp. | 251.6 | 226.5 | 223.5 | 223.3 | 219.6 | 208.9 | 199.3 | 190.1 | 192.9 | 181.2 | 180.8 | 178.6 | 183.6 | |
Operating Profit | 54.1 | 55.5 | 50.3 | 43.8 | 50.2 | 40.9 | 35.5 | 36.8 | 41.8 | 35.7 | 36.1 | 31.7 | 33.3 | |
Operating Profit Margin % | 17.69% | 19.68% | 18.37% | 16.40% | 18.59% | 16.36% | 15.14% | 16.23% | 17.81% | 16.45% | 16.65% | 15.08% | 15.36% | |
Depr. | 14.1 | 12.4 | 12.4 | 12.1 | 11.2 | 10.7 | 11.3 | 10.9 | 10.6 | 10.2 | 10.5 | 9.6 | 9.4 | |
Interest | 7.4 | 6.4 | 6.3 | 6.6 | 6.9 | 7.1 | 7.5 | 7.7 | 7.6 | 7.7 | 8.1 | 7.6 | 7.5 | |
Profit Before Tax | 40.8 | 42.1 | 39.3 | 29.6 | 39.8 | 30.1 | 29 | 27 | 31.1 | 22.1 | 19.4 | 16.3 | 18.9 | |
Tax | 9.8 | 11.1 | 9.7 | 7.1 | 9.8 | 8.7 | 5.8 | 6.3 | 8.5 | 5.2 | 5.5 | 4.8 | 5.2 | |
Net Profit | 31 | 31.1 | 29.6 | 22.5 | 30 | 21.4 | 23.2 | 20.8 | 22.6 | 16.9 | 13.9 | 11.5 | 13.8 | |
EPS Adj. latest | 2 | 2 | 1.9 | 1.4 | 1.9 | 1.4 | 1.5 | 1.3 | 1.4 | 1.1 | 0.9 | 0.7 | 0.9 | |
Net profit TTM | 114.1 | 113.1 | 103.4 | 97.1 | 95.4 | 88 | 83.5 | 74.2 | 64.9 | 56.1 | 49.2 | 45.6 | 44.9 | |
Basic EPS TTM | 7.2 | 7.1 | 6.5 | 6.1 | 6.9 | 6.3 | 6.1 | 5.4 | 4.7 | 4.1 | 3.6 | 3.4 | 3.3 | |
Earnings Transcripts | ||||||||||||||
Results PDF | ||||||||||||||
Result Notes |
Artemis Medicare Serv Technical Analysis
Artemis Medicare Serv EMA & SMA
| 5 Day | 295.8 |
|---|---|
| 10 Day | 298.5 |
| 12 Day | 300.1 |
| 20 Day | 306.1 |
| 26 Day | 309.3 |
|---|---|
| 50 Day | 312.2 |
| 100 Day | 302.8 |
| 200 Day | 286.3 |
Artemis Medicare Serv Delivery And Volume
Artemis Medicare Serv Resistance and Support
| First Resistance | 301 |
|---|---|
| Second Resistance | 308.8 |
| Third Resistance | 315.5 |
| First Support | 286.6 |
|---|---|
| Second Support | 279.9 |
| Third Support | 272.1 |
| Day RSI | 38.6 |
|---|---|
| Day MACD | -9.2 |
| Day MFI | 24.6 |
| Day MACD Signal Line | -8.5 |
Artemis Medicare Serv Beta
| 1 Month | 1.0 |
|---|---|
| 1 Year | 0.8 |
| 3 Month | 0.8 |
|---|---|
| 3 Year | 0.9 |
Artemis Medicare Serv Price Change Analysis
Artemis Medicare Serv Deals - Insider, Bulk, Block and SAST
| Client Name | Deal Type | Action | Date | Avg. Price | Quantity | Exchange |
|---|---|---|---|---|---|---|
| MICROCURVES TRADING PRIVATE LIMITED | Bulk | Sell | 25 Sep 2026 | 366.15 | 1,004,061 | NSE |
| MICROCURVES TRADING PRIVATE LIMITED | Bulk | Purchase | 25 Sep 2026 | 365.80 | 1,004,061 | NSE |
Artemis Medicare Serv Corporate Actions
Artemis Medicare Serv Dividend history and yield
Artemis Medicare Serv dividend yields, including actual and adjusted, and dividend history, including announcement, record, and ex-dividend dates. Track Artemis Medicare Serv dividend yield over time.
#Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
110 Jul 2026 | 0.45 | FINAL | 10 Jul 2026 | Equity Share |
211 Jul 2025 | 0.45 | FINAL | 11 Jul 2025 | Equity Share |
305 Jul 2024 | 0.45 | FINAL | 05 Jul 2024 | Equity Share |
414 Jul 2023 | 0.45 | FINAL | 14 Jul 2023 | Equity Share |
Artemis Medicare Serv Board Meetings
Artemis Medicare Serv past and upcoming board meetings.
#Ex-Date | Purpose | Notes |
|---|---|---|
130 Oct 2026 | Quarterly Results | - |
203 Aug 2026 | Quarterly Results | - |
304 Jun 2026 | Others | To consider Other business matters. |
408 May 2026 | Audited Results & Final Dividend | - |
502 Feb 2026 | Quarterly Results & Others | - |
Artemis Medicare Serv Stock Split
Artemis Medicare Serv stock split details, including announcement, record, and ex-split dates, along with the split ratios
#Ex-Date | Old FV | New FV | Record Date |
|---|---|---|---|
123 Sep 2021 | 10 | 1 | 24 Sep 2021 |
Artemis Medicare Serv Research Reports
Artemis Medicare Serv research reports with share price targets, and buy/hold/sell recommendations from top brokers.
# Date | Broker Name | Target | Price When Recommended | Type | Upside | Change Since Recommendation | Links |
|---|---|---|---|---|---|---|---|
| 109 Sep 2026 | ICICI Direct Target | 410 | 348.55 | Buy | 17.63% | -15.88% | |
| 224 May 2026 | ICICI Direct | 340 | 287.92 | Buy | 18.09% | 1.83% | |
| 310 May 2026 | ICICI Direct | 340 | 281.12 | Buy | 20.94% | 4.3% | |
| 404 Apr 2023 | Ventura | 134 | 68.1 | Buy | 96.77% | 330.54% |
Artemis Medicare Serv Corporate Filings
Artemis Medicare Serv BSE corporate filings and AGM, press releases, insider trading & SAST, results and corporate actions.
| Date | Announcement Title | Details | Links |
|---|---|---|---|
| 31 Oct 2026 | Artemis Medicare Services Ltd - 542919 - Announcement under Regulation 30 (LODR)-Newspaper Publication | Newspaper Publication - October 31, 2026 | |
| 30 Oct 2026 | Artemis Medicare Services Ltd - 542919 - Announcement under Regulation 30 (LODR)-Monitoring Agency Report | Monitoring Agency Report for the quarter ended September 30, 2026 | |
| 30 Oct 2026 | Q2FY27 Quarterly Result Announced for Artemis Medicare Services Ltd. | Healthcare Facilities company Artemis Medicare Services announced Q2FY27 results Consolidated Financial Highlights: Revenue from Operations: Rs 31,104.14 lakh in Q2FY27, indicating an increase of 8.25% QoQ from Rs 28,732.35 lakh in Q1FY27 and an increase of 13.23% YoY from Rs 27,470.28 lakh in Q2FY26. For H1FY27, Revenue from Operations stood at Rs 59,836.49 lakh, up 12.97% YoY from Rs 52,966.37 lakh in H1FY26. Total Income: Rs 31,911.72 lakh in Q2FY27, reflecting an increase of 9.03% QoQ compared to Rs 29,269.74 lakh in Q1FY27 and an increase of 13.02% YoY compared to Rs 28,235.72 lakh in Q2FY26. For H1FY27, Total Income reached Rs 61,181.46 lakh, showing a YoY growth of 12.42% from Rs 54,424.60 lakh in H1FY26. Profit Before Tax (PBT): Rs 4,097.61 lakh in Q2FY27, showing a decline of 3.88% QoQ from Rs 4,263.04 lakh in Q1FY27 and an increase of 4.06% YoY from Rs 3,937.58 lakh in Q2FY26. For H1FY27, PBT registered at Rs 8,360.64 lakh, growing 20.89% YoY against Rs 6,916.02 lakh in H1FY26. Net Profit After Tax (PAT): Rs 3,109.95 lakh in Q2FY27, down 1.09% QoQ from Rs 3,144.27 lakh in Q1FY27 but up 3.66% YoY from Rs 3,000.22 lakh in Q2FY26. For H1FY27, PAT stood at Rs 6,254.22 lakh, gaining 22.15% YoY against Rs 5,119.97 lakh in H1FY26. Earning per Equity Share (EPS) - Basic: Rs 1.96 in Q2FY27, dropping 1.01% QoQ from Rs 1.98 in Q1FY27 and increasing 3.16% YoY from Rs 1.90 in Q2FY26. For H1FY27, Basic EPS stood at Rs 3.94, increasing 21.23% YoY from Rs 3.25 in H1FY26. Earning per Equity Share (EPS) - Diluted: Rs 1.96 in Q2FY27, down 1.01% QoQ from Rs 1.98 in Q1FY27 and up 3.16% YoY from Rs 1.89 in Q2FY26. For H1FY27, Diluted EPS was Rs 3.94, rising 21.60% YoY from Rs 3.24 in H1FY26. Standalone Financial Highlights: Revenue from Operations: Rs 30,570.62 lakh in Q2FY27, demonstrating a growth of 8.40% QoQ from Rs 28,200.97 lakh in Q1FY27 and a growth of 13.32% YoY from Rs 26,978.31 lakh in Q2FY26. For H1FY27, Revenue from Operations recorded at Rs 58,771.59 lakh, growing 13.11% YoY compared to Rs 51,958.17 lakh in H1FY26. Total Income: Rs 31,388.56 lakh in Q2FY27, reflecting an increase of 9.21% QoQ against Rs 28,740.55 lakh in Q1FY27 and a rise of 13.08% YoY against Rs 27,756.66 lakh in Q2FY26. For H1FY27, Total Income was Rs 60,129.11 lakh, rising 12.53% YoY from Rs 53,432.28 lakh in H1FY26. Profit Before Tax (PBT): Rs 4,076.28 lakh in Q2FY27, marking a decrease of 3.20% QoQ from Rs 4,210.98 lakh in Q1FY27 and an expansion of 2.50% YoY from Rs 3,976.87 lakh in Q2FY26. For H1FY27, PBT stood at Rs 8,287.26 lakh, increasing 18.67% YoY from Rs 6,983.58 lakh in H1FY26. Net Profit After Tax (PAT): Rs 3,095.31 lakh in Q2FY27, lower by 0.32% QoQ from Rs 3,105.11 lakh in Q1FY27 and higher by 3.30% YoY from Rs 2,996.45 lakh in Q2FY26. For H1FY27, PAT recorded at Rs 6,200.42 lakh, growing 20.67% YoY from Rs 5,138.17 lakh in H1FY26. Earning per Equity Share (EPS) - Basic & Diluted: Both parameters stood at Rs 1.96 in Q2FY27, which is unchanged QoQ from Rs 1.96 in Q1FY27, while expanding by 3.16% YoY (Basic) and 3.70% YoY (Diluted) against the Q2FY26 figures of Rs 1.90 and Rs 1.89 respectively. For H1FY27, Basic and Diluted EPS reached Rs 3.92, increasing 20.25% YoY (Basic) and 20.62% YoY (Diluted) compared to Rs 3.26 and Rs 3.25 in H1FY26. Business Highlights: Geographical Performance Breakdown: Domestic operations inside India recorded a revenue from operations of Rs 22,226.93 lakh in Q2FY27 compared to Rs 21,081.83 lakh in Q1FY27 and Rs 19,221.56 lakh in Q2FY26. For H1FY27, geographical revenue from India stood at Rs 43,308.76 lakh compared to Rs 37,674.43 lakh in H1FY26. Operations outside India registered a revenue from operations of Rs 8,811.21 lakh in Q2FY27 compared to Rs 7,650.52 lakh in Q1FY27 and Rs 8,248.12 lakh in Q2FY26. For H1FY27, geographical revenue from outside India stood at Rs 16,521.13 lakh compared to Rs 15,291.94 lakh in H1FY26. Onkar Kanwar, Chairman, Artemis Medicare Services, said: “We have delivered a steady performance in the second quarter of FY27, with consolidated revenue growing 13.0% YoY. This reflects the resilience of our business model, sustained demand for quality healthcare services, and our continued focus on disciplined execution. The commencement of operations at our Raipur hospital in July 2026 marks an important milestone in Artemis’ growth journey, expanding our presence into new markets and extending access to advanced healthcare services beyond our established Gurugram centre. As we build out our healthcare platform, we remain committed to a calibrated approach to expansion, with a focus on clinical excellence, operational sustainability, and prudent capital allocation. Looking ahead, we will continue to strengthen our core operations while progressing our strategic expansion plans. With a clear long-term vision and an unwavering commitment to quality healthcare, we remain focused on building a resilient healthcare platform that creates sustainable value for our patients, employees, stakeholders, and shareholders.” Devlina Chakravarty, Managing Director, Artemis Medicare Services, said: “The second quarter of FY27 reflects continued momentum in our core Gurugram operations, supported by healthy revenue growth, improved occupancy, and stronger operating profitability. The hospital recorded year-on-year revenue growth of 14.5%, while Ops. EBITDA and PAT grew by 26.3% and 25.9%, respectively. Improved bed occupancy of 68.1% and higher average revenue per occupied bed further demonstrate the strength of our operating performance and the sustained demand for our specialised clinical services. At the consolidated level, revenue from operations grew 13.2% YoY, while Adjusted EBITDA* increased by 22.7%, reflecting underlying operating progress. Our priorities remain centred on enhancing operational efficiencies, maintaining disciplined cost management, strengthening clinical capabilities, and delivering consistently high standards of patient care. With the commencement of operations at our Raipur hospital in July 2026, we have entered an important new phase of expansion. Our focus is now on progressively building clinical capabilities, expanding specialised services, and establishing the facility as a trusted destination for advanced healthcare in Central India. Going forward, we will continue to strengthen our existing operations and pursue measured expansion, with the objective of building a future-ready healthcare platform that delivers superior clinical outcomes and sustainable long-term value for all our stakeholders.” Result PDF | |
| 30 Oct 2026 | Artemis Medicare Services Ltd - 542919 - Announcement under Regulation 30 (LODR)-Investor Presentation | Earnings Presentation - Q2 and H1 FY27 | |
| 30 Oct 2026 | Artemis Medicare Services Ltd - 542919 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | Press Release - October 30, 2026 |
Artemis Medicare Serv Documents
Artemis Medicare Serv Earnings Call
Artemis Medicare Serv earnings calls, including management commentary and AI-generated summaries.
| Date | Title | Links |
|---|---|---|
| 10 Aug 2026 | Artemis Medicare Services Ltd - 542919 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript | Link |
| 04 Aug 2026 | Artemis Medicare Services Ltd - 542919 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | Link |
| 15 May 2026 | Artemis Medicare Services Ltd - 542919 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript | Link |
| 11 May 2026 | Artemis Medicare Services Results Earnings Call for Q4FY26 & Full Year | AudioVideo |
| 09 Feb 2026 | Artemis Medicare Services Ltd - 542919 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript | Link |
Artemis Medicare Serv Annual Reports
Artemis Medicare Serv financials, including annual results, balance sheets, and cash flow statements.
Artemis Medicare Serv Credit Ratings
Artemis Medicare Serv credit ratings from CRISIL and leading rating agencies, assessing financial stability, investment grade, and related PDF documentation.
Artemis Medicare Serv Investor Presentations
Artemis Medicare Serv investor presentations, including business updates, financial insights, and strategic initiatives.
| Date | Report Title | Links |
|---|---|---|
| 30 Oct 2026 | Artemis Medicare Services Ltd - 542919 - Announcement under Regulation 30 (LODR)-Investor Presentation | Link |
| 03 Aug 2026 | Artemis Medicare Services Ltd - 542919 - Announcement under Regulation 30 (LODR)-Investor Presentation | Link |
| 08 May 2026 | Artemis Medicare Services Ltd - 542919 - Announcement under Regulation 30 (LODR)-Investor Presentation | Link |
| 02 Feb 2026 | Artemis Medicare Services Ltd - 542919 - Announcement under Regulation 30 (LODR)-Investor Presentation | Link |
| 11 Nov 2025 | Artemis Medicare Services Ltd - 542919 - Announcement under Regulation 30 (LODR)-Investor Presentation | Link |
Artemis Medicare Serv - Company Profile
Artemis Medicare Serv Management Structure
Artemis Medicare Serv management structure with salaries, total experience, and qualifications.
Artemis Medicare Serv Board of Directors
Artemis Medicare Serv Board of directors with salaries, total experience, and qualifications.
About the company - Business Profile
Artemis Medicare Services Ltd. (Artemis) is a tertiary care healthcare provider established in 2007 by the promoters of the Apollo Tyres Group. The company operates its flagship facility, Artemis Hospital, in Gurugram, India, which is a multi-specialty institution. Artemis holds the distinction of being the first hospital in Gurugram to receive accreditation from both the Joint Commission International (JCI), USA, and the National Accreditation Board for Hospitals & Healthcare Providers (NABH).
The company provides advanced medical and surgical interventions across more than 40 medical specialties, supported by 14 centers of excellence. Its primary market position is centered in the Delhi-NCR region, though it has recently expanded its geographical footprint through new facilities in New Gurugram and international operations in Mauritius.
Key Points
- Key Facts:
- Founded: 2007.
- Headquarters: Gurugram, Haryana.
- Promoter Group: Apollo Tyres Group (Constructive Finance Pvt Ltd holds 66.5% as of September 2025).
- Stock Listing: NSE and BSE (Stock Code: ARTEMISMED).
- Operations and Resources:
- Flagship Facility: 700-bed super-specialty hospital in Gurugram spread across 8.23 acres.
- International Presence: Operates the 80-bed Artemis Curepipe Hospital in Mauritius (commenced in FY24).
- Expansion Pipeline: Plans to reach approximately 2,000 beds by 2028. Key projects include a 300+ bed hospital in Raipur (expected April/May 2026) and a 650+ bed facility planned for South Delhi.
- Ownership Structure (as of Sept 2025):
- Promoters: 66.5%.
- Government (Kerala State): ~7.1% (Governor of Kerala and KSIDC).
- Public/Others: ~26.4% (including DIIs like HSBC Focused Fund and LIC Mutual Fund).
- Business Model and Competencies:
- The company operates a fee-for-service model involving inpatient (IPD) and outpatient (OPD) services.
- It is recognized for its high clinical outcomes in complex procedures such as oncology, cardiology, and organ transplants.
- A significant portion of its revenue is driven by international medical tourism and insured patients.
- Revenue Breakdown (FY25 - Consolidated):
- Total Revenue from Operations: Rs. 91,326.13 Lakhs (Standalone) / Rs. 93,691.67 Lakhs (Consolidated).
- Geographical Split (H1 FY26):
- India: ~68% (Rs. 32,188 Lakhs).
- Outside India: ~32% (Rs. 15,294 Lakhs).
- Specialty Segmentation (FY25):
- Oncology: 20%.
- Cardiology: 17%.
- Neurosciences: 14%.
- Internal Medicine: 14%.
- Gastroenterology: 4%.
- Liver Transplant: 3%.
- Nephrology: 3%.
- Technological Advancements and Services:
- The hospital utilizes high-end medical technology for complex surgeries, recently noted for removing a 10 kg abdominal tumor and performing intricate ENT surgeries involving the brain and spine.
- Artemis Lite: A brand launched to cater to fast-developing residential areas with focused healthcare services.
- Human Resources:
- The company employs over 500 doctors.
- While specific attrition rates for FY25 are not explicitly detailed in the brief, the company has issued equity shares to its Managing Director under the Employee Stock Option Plan (ESOP) 2021 to align leadership incentives.
- Current Strategic Initiatives:
- Asset-Light Expansion: Focusing on Management & Operations (O&M) contracts for international and some domestic expansions.
- Digital Transformation: Enhancing patient engagement and operational efficiency through integrated hospital management systems.
References
